• 40% faster test case creation
• $2.4M in annual QA labor savings
• Accelerated time-to-market for new therapies
  
  

Business Context

The company’s manual QA process strained under the demands of biopharma’s strict regulatory environment:

• Slow Test Authoring: Manual creation of thousands of test cases delayed releases.
• Compliance Risk: Incomplete coverage jeopardized audit readiness.
• High Labor Costs: QA teams spent disproportionate time on repetitive tasks.
• Limited Collaboration: Misalignment between QA and product slowed feedback loops.
• Innovation Bottleneck: Slow QA cycles delayed drug and therapy rollouts.
  
  

Solution

Forte Group developed an AI-powered Test Automation Assistant to streamline QA processes while meeting compliance requirements.

Key components included:

• Automated Test Generation: AI authored test cases from requirements and user stories.
• Coverage Validation: Ensured all regulatory and functional requirements were represented.
• Audit Trails: Complete documentation to satisfy compliance audits.
• Continuous Integration: Integrated seamlessly into existing QA workflows.
• Collaboration Features: Improved alignment between QA, product, and compliance teams.
• Iterative Learning: AI refined outputs based on feedback from QA specialists.

Results & Value Delivered

• 40% faster test case creation across QA teams
• $2.4M in annual labor savings from reduced manual effort
• Improved compliance confidence with complete audit-ready documentation
• Shortened release cycles, accelerating time-to-market for new therapies
• QA staff redeployed to focus on higher-value testing and validation
• Stronger collaboration between QA and product teams, improving product quality
  
  

AI-powered automation reduced test authoring time by 40%, saving ~$2.4M annually and accelerating time-to-market while ensuring audit-ready compliance.